Cover Image
市場調查報告書

Tropisetron的中國市場

Investigation Report on China Tropisetron Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332306
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Tropisetron的中國市場 Investigation Report on China Tropisetron Market, 2010-2019
出版日期: 2015年06月04日 內容資訊: 英文 30 Pages
簡介

由Novartis所開發,1992年在荷蘭核可上市的Tropisetron,在1990年代後半打入中國市場。2005年在中國僅4100萬人民幣的Tropisetron銷售量,之後便以34.7%的年複合成長率擴大,到2014年已達到6億人民幣的規模。

本報告提供中國的Tropisetron市場規模與今後預測,提供您主要製藥公司及劑型別市場佔有率,銷售價格等資訊。

第1章 Tropisetron的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國Tropisetron的市場簡介

  • Tropisetron的專利及核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國Tropisetron銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國Tropisetron的主要製藥公司市場佔有率調查

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國Tropisetron的劑型的相關調查

  • 劑型別市場佔有率:以銷售額為準
  • 劑型別市場佔有率:以銷售量為準

第6章 中國醫院的Tropisetron的標準價格

  • Wellso Pharmaceutical Co., Ltd (Shu Ou Ting)
  • Beijing SL Pharmaceutical Co., Ltd
  • Sichuan Taiji Pharmaceutical Co., Ltd., Taiji Group
  • Shandong Linzi Pharmaceutical Co., Ltd
  • ReYoung Pharmaceutical Co., Ltd
  • Shandong Luoxin Pharmacy Stock Co., Ltd
  • Qilu Pharmaceutical Co., Ltd
  • Jiangsu Hengrui Medicine Co., Ltd
  • Lionco Pharmaceutical Group
  • Southwest Pharamceutical Co., Ltd
  • Harbin Medisan Pharmaceutical Co., Ltd

第7章 中國市場中Tropisetron的主要製藥公司

  • ReYoung Pharmaceutical Co., Ltd
  • Shandong Luoxin Pharmacy Stock Co., Ltd
  • Qilu Pharmaceutical Co., Ltd
  • Southwest Pharamceutical Co., Ltd
  • Wellso Pharmaceutical Co., Ltd

第8章 中國Tropisetron的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506199

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may even feel unwilling or give up further chemotherapy, which will make chemotherapy difficult to continue. 5-HT3 receptor antagonist, an antiemetic, acts by competitively preventing 5-HT from combining with 5-HT3 receptor. Ever since GSK developed the first generation of selective 5-HT3 receptor antagonist ondansetron under the trade name of Zofran, a bunch of derivatives have come out, including tropisetron made by Novartis under the trade name of Navoban.

Tropisetron, developed by Novartis, entered the market in the Netherlands in 1992 and then the Chinese market in the late 1990s. Tropisetron got administrative protection authorized by the Chinese government in Mar. 1994 after its original developer Sandoz submitted application. But it is now a generic drug for its patent expired on Sep. 22, 2001. Tropisetron develops fast into the absolute leader antiemetics after entering China with annual sales rising from CNY 41 million in 2005 to CNY 600 million in 2014 and CAGR reaching up to 34.7% during the period of 2005-2014. Currently, the tropisetron market in China is basically occupied by generic drugs which come from the following companies: Southwest Pharamceutical Co., Ltd, Wellso Pharmaceutical Co., Ltd, ReYoung Pharmaceutical Co., Ltd, Shandong Luoxin Pharmacy Stock Co., Ltd and Qilu Pharmaceutical Co., Ltd

Tropisetron has big profit margins and is easy to be applied to clinics. Since there are hundreds of thousands of cancer patients undergoing chemoradiotherapy, tropisetron enjoys a promising market in China.

Readers can get at least the following information through this report:

  • market share of manufacturers of tropisetron in Chinese market
  • price of tropisetron in Chinese market
  • major manufacturers of tropisetron in China
  • share of different dosage forms of tropisetron in Chinese market
  • market outlook of tropisetron in China

The author suggests the following groups of people purchase this report:

  • pharmaceutical enterprises
  • investors/ research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Tropisetron

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Tropisetron in China

  • 2.1. Patent and Approval Status of Tropisetron in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Tropisetron in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Tropisetron in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Tropisetron in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Tropisetron in Chinese Hospitals in 2014

  • 6.1. Wellso Pharmaceutical Co., Ltd (Trade Name: Shu Ou Ting)
  • 6.2. Beijing SL Pharmaceutical Co., Ltd
  • 6.3. Sichuan Taiji Pharmaceutical Co., Ltd., Taiji Group
  • 6.4. Shandong Linzi Pharmaceutical Co., Ltd
  • 6.5. ReYoung Pharmaceutical Co., Ltd
  • 6.6. Shandong Luoxin Pharmacy Stock Co., Ltd
  • 6.7. Qilu Pharmaceutical Co., Ltd
  • 6.8. Jiangsu Hengrui Medicine Co., Ltd
  • 6.9. Lionco Pharmaceutical Group
  • 6.10. Southwest Pharamceutical Co., Ltd
  • 6.11. Harbin Medisan Pharmaceutical Co., Ltd

7. Major Manufacturers of Tropisetron in Chinese Market, 2010-2014

  • 7.1. ReYoung Pharmaceutical Co., Ltd
  • 7.2. Shandong Luoxin Pharmacy Stock Co., Ltd
  • 7.3. Qilu Pharmaceutical Co., Ltd
  • 7.4. Southwest Pharamceutical Co., Ltd
  • 7.5. Wellso Pharmaceutical Co., Ltd

8. Market Outlook of Tropisetron in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Approval Information of Tropisetron in China
  • Chart Sales Status of Tropisetron in China, 2010-2014
  • Chart Sales Value of Tropisetron in China, 2010-2014
  • Chart Sales Value of Tropisetron in Some Regions in China, 2010-2014
  • Chart Sales Volume of Tropisetron in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Tropisetron for Sales Volume in China, 2010-2014
  • Chart Sales Value and Market Share of Tropisetron Made by Southwest Pharamceutical in China, 2010-2014
  • Chart Sales Value and Market Share of Tropisetron Made by Qilu Pharmaceutical in China, 2010-2014
  • Chart Sales Value and Market Share of Tropisetron Made by Wellso in China, 2010-2014
  • Chart Sales Value and Market Share of Tropisetron Injection in China, 2010-2014
  • Chart Price of Tropisetron Made by Wellso Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by Beijing SL Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by Shandong Luoxin Pharmacy Stock Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by Jiangsu Hengrui Medicine Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by Southwest Pharamceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tropisetron Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top